Literature DB >> 30187299

Abernethy malformation: Single-center experience from India with review of literature.

Swapnil Sharma1, Prashant R Bobhate2, Shailesh Sable3, Suneed Kumar3, Kapildev Yadav3, Sharad Maheshwari4, Saista Amin5, Ashutosh Chauhan3, Vibha Varma3, Sorabh Kapoor3, Vinay Kumaran3.   

Abstract

Abernethy malformation is a rare congenital anomaly in which there is direct communication between the portal and systemic venous circulation. The clinical presentation ranges from asymptomatic with incidental detection on imaging to secondary complications of disease or related to associate anomalies. This is a retrospective analysis of data from nine patients with Abernethy malformation at a single center. This is a referral center for Pediatric Cardiology and for Hepatobiliary and Pancreatic Surgery. The patients presented to the Pulmonary Hypertension Clinic/the Hepatobiliary Surgery Clinic. Out of nine patients, four were male. Type II Abernethy malformation was present in five patients whereas three patients had type I malformation. One of the patients had communication between inferior mesenteric vein and internal iliac vein. Five out of nine patients were erroneously diagnosed as idiopathic primary pulmonary hypertension and were treated with vasodilators. One patient required living donor liver transplant. One patient was managed with surgical shunt closure whereas two patients required transcatheter shunt closure. The rest of the patients were managed conservatively. Abernethy malformation is more common than previously thought and the diagnosis is often missed. There are various management options for Abernethy malformation, which includes surgical or transcatheter shunt closure and liver transplant. Management of Abernethy malformation depends upon type, presentation, and size of shunt.

Entities:  

Keywords:  Abernethy malformation; Congenital portosystemic shunt; Liver transplantation; Transcatheter shunt closure

Mesh:

Year:  2018        PMID: 30187299     DOI: 10.1007/s12664-018-0884-3

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  22 in total

1.  Portohepatic shunt in a Down syndrome patient with an interchange trisomy 47,XY,-2,+der(2),+der(21)t(2;21)(p13;q22.1)mat.

Authors:  M W Kieran; M Vekemans; L J Robb; A Sinsky; E W Outerbridge; V M Der Kaloustian
Journal:  Am J Med Genet       Date:  1992-10-01

2.  Type 2 Abernethy malformation presenting as a portal vein-coronary sinus fistula.

Authors:  Rohit S Loomba; Grzegorz W Telega; Todd M Gudausky
Journal:  J Pediatr Surg       Date:  2012-05       Impact factor: 2.545

3.  Congenital absence of the portal vein and role of liver transplantation in children.

Authors:  M Shinkai; Y Ohhama; T Nishi; H Yamamoto; S Fujita; H Take; M Adachi; K Tachibana; N Aida; K Kato; Y Tanaka; S Takemiya
Journal:  J Pediatr Surg       Date:  2001-07       Impact factor: 2.545

4.  Resolution of hepatopulmonary syndrome after ligation of a portosystemic shunt in a pediatric patient with an Abernethy malformation.

Authors:  Nobuyuki Morikawa; Toshiro Honna; Tatsuo Kuroda; Yoshihiro Kitano; Yasushi Fuchimoto; Noriko Kawashima; Kazuteru Kawasaki
Journal:  J Pediatr Surg       Date:  2008-02       Impact factor: 2.545

5.  An unusual case of cyanosis in a young boy.

Authors:  Venigalla Pratap Mouli; Shivanand Gamnagatti; Vineet Ahuja
Journal:  Gastroenterology       Date:  2013-12       Impact factor: 22.682

Review 6.  Cardiac anomalies associated with congenital absence of the portal vein.

Authors:  M Massin; A Verloes; P Jamblin
Journal:  Cardiol Young       Date:  1999-09       Impact factor: 1.093

7.  [Congenital absence of portal vein in a girl with biliary atresia treated with liver transplant].

Authors:  K A Taoube; J L Alonso Calderón; T Yandza; D St Vil; H Blanchard
Journal:  Cir Pediatr       Date:  1999-01

8.  Congenital absence of the portal vein in oculoauriculovertebral dysplasia (Goldenhar syndrome).

Authors:  S S Morse; K J Taylor; E B Strauss; E Ramirez; J H Seashore
Journal:  Pediatr Radiol       Date:  1986

9.  An infant with pulmonary hypertension due to a congenital porto-caval shunt.

Authors:  Jörg Ersch; Oskar Bänziger; Christian Braegger; Urs Arbenz; Thomas Stallmach
Journal:  Eur J Pediatr       Date:  2002-11-08       Impact factor: 3.183

10.  Congenital portosystemic shunts in children: a new anatomical classification correlated with surgical strategy.

Authors:  Thomas Blanc; Florent Guerin; Stéphanie Franchi-Abella; Emmanuel Jacquemin; Danièle Pariente; Olivier Soubrane; Sophie Branchereau; Frédéric Gauthier
Journal:  Ann Surg       Date:  2014-07       Impact factor: 12.969

View more
  5 in total

Review 1.  Can intestinal microbiota and circulating microbial products contribute to pulmonary arterial hypertension?

Authors:  Thenappan Thenappan; Alexander Khoruts; Yingjie Chen; E Kenneth Weir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-09-06       Impact factor: 4.733

2.  Case Report: Membranoproliferative Glomerulonephritis, a Rare Clinical Manifestation of Abernethy Malformation Type II.

Authors:  Xue He; Yueling Zhu; Haidong Fu; Chunyue Feng; Zhixia Liu; Weizhong Gu; Yanyan Jin; Binbin Yang; Huijun Shen
Journal:  Front Pediatr       Date:  2021-03-17       Impact factor: 3.418

3.  Congenital extrahepatic portocaval malformation: Rare but potentially treatable cause of pulmonary hypertension.

Authors:  Prashant Bobhate; Sandeep Garg; Anuj Sharma; Diptiman Roy; Abhijeet Raut; Ravindra Pawar; Tanuja Karande; Snehal Kulkarni
Journal:  Indian Heart J       Date:  2020-12-30

4.  Case report: Congenital extrahepatic portocaval shunt presenting as pulmonary arterial hypertension in a pregnant patient.

Authors:  Matevž Harlander; Maja Badovinac; Frosina Markoska; Barbara Salobir; Tomaž Štupnik; Marija Iča Dolenšek; Izidor Kern; Vojka Gorjup; Nazzareno Galiè
Journal:  Pulm Circ       Date:  2022-01-03       Impact factor: 2.886

5.  A case report on an incidental discovery of congenital portosystemic shunt.

Authors:  Daniela Păcurar; Irina Dijmărescu; Adrian Dumitru Dijmărescu; Mihai Romaşcanu; Cristina Adriana Becheanu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.